Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 22501 AL 22515

Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research

Smith EE, Phillips NA, Feldman HH, Borrie M, Ganesh A, Henri-Bhargava A, Desmarais P, Frank A, Badhwar A, Barlow L, Bartha R, Best S, Bethell J, Bhangu J, Black SE, Bocti C, Bronskill SE, Burhan AM, Calon F, Camicioli R, Campbell B, Collins DL, Dadar M, DeMarco ML, Ducharme S, Duchesne S, Einstein G, Fisk JD, Gawryluk JR, Grossman L, Ismail Z, Itzhak I, Joshi M, Harrison A, Kröger E, Kumar S, Laforce R, Lanctot KL, Lau M, Lee L, Masellis M, Massoud F, Mitchell SB, Montero-Odasso M, Myers Barnett K, Nygaard HB, Pasternak SH, Peters J, Rajah MN, Robillard JM, Rockwood K, Rosa-Neto P, Seitz DP, Soucy JP, Trenaman SC, Wellington CL, Zadem A, Chertkow H; Canadian Consortium on Neurodegeneration in Aging Investigators.

J Prev Alzheimers Dis. 2025 Mar;12(3):100068. doi: 10.1016/j.tjpad.2025.100068. Epub 2025 Jan 31.

Improvements in Exercise for Alzheimer's Disease: Highlighting FGF21-Induced Cerebrovascular Protection

Wang J, Meng X, Yang J, Tang Y, Zeng F, Wang Y, Chen Z, Chen D, Zou R, Liu W.

Neurochem Res. 2025 Feb 4;50(2):95. doi: 10.1007/s11064-025-04350-w.

Massive changes in gene expression and their cause(s) can be a unifying principle in the pathobiology of Alzheimer's disease

Coleman PD, Delvaux E, Kordower JH, Boehringer A, Huseby CJ.

Alzheimers Dement. 2025 Feb;21(2):e14555. doi: 10.1002/alz.14555. Epub 2025 Feb 6.

Lipoic acid scaffold applications in the design of multitarget-directed ligands against Alzheimer's disease

Manavi MA, Nourhashemi M, Emami S, Fathian Nasab MH, Dehnavi F, Küçükkılınç TT, Foroumadi A, Sharifzadeh M, Khoobi M.

Bioorg Chem. 2025 Apr;157:108241. doi: 10.1016/j.bioorg.2025.108241. Epub 2025 Feb 3.

Understanding of Alzheimer's disease pathophysiology for therapeutic implications of natural products as neuroprotective agents

Prabha S, Choudhury A, Islam A, Thakur SC, Hassan MI.

Ageing Res Rev. 2025 Mar;105:102680. doi: 10.1016/j.arr.2025.102680. Epub 2025 Feb 6.

Exploring the potential of acupuncture as a complementary treatment for Alzheimer's disease: Pushing the boundaries forward

Silva RPDS, Barbosa BJAP.

J Alzheimers Dis. 2025 Mar;104(2):331-333. doi: 10.1177/13872877251316572. Epub 2025 Feb 9.

Modulating Neuroinflammation as a Prospective Therapeutic Target in Alzheimer's Disease

Lee E, Chang Y.

Cells. 2025 Jan 22;14(3):168. doi: 10.3390/cells14030168.

Exploring Quinazoline as a Scaffold for Developing Novel Therapeutics in Alzheimer's Disease

Abualassal Q, Abudayeh Z, Sirhan A, Mkia A.

Molecules. 2025 Jan 26;30(3):555. doi: 10.3390/molecules30030555.

Beyond plaques and tangles: The role of immune cell dysfunction in Alzheimer's disease

Hussain N, Khan MM, Sharma A, Singh RK, Khan RH.

Neurochem Int. 2025 Mar;184:105947. doi: 10.1016/j.neuint.2025.105947. Epub 2025 Feb 14.

Traversing Shifting Sands-the Challenges of Caring for Someone With Alzheimer's Disease and the Impact on Care Partners: Social Media Content Analysis

Frederiksen KS, Hahn-Pedersen J, Crawford R, Morrison R, Jeppesen R, Doward L, Weidner W.

J Med Internet Res. 2025 Feb 18;27:e55468. doi: 10.2196/55468.

Utilization of precision medicine digital twins for drug discovery in Alzheimer's disease

Ren Y, Pieper AA, Cheng F.

Neurotherapeutics. 2025 Apr;22(3):e00553. doi: 10.1016/j.neurot.2025.e00553. Epub 2025 Feb 17.

Polypharmacology and Neuroprotective Effects of Gingerol in Alzheimer's Disease

Priyadarshini S, Goyal K, R R, Gupta S, Roy A, Biswas R, Patra S, Chauhan P, Wadhwa K, Singh G, Kamal M, Iqbal D, Alsaweed M, Nuli MV, Abomughaid MM, Almutary AG, Sinha JK, Bansal P, Rani B, Walia C, Sivaprasad GV, Ojha S, Nelson VK, Jha NK.

Mol Neurobiol. 2025 Jul;62(7):8166-8186. doi: 10.1007/s12035-024-04484-y. Epub 2025 Feb 21.

Peripheral and central neuroimmune mechanisms in Alzheimer's disease pathogenesis

Zhang S, Gao Y, Zhao Y, Huang TY, Zheng Q, Wang X.

Mol Neurodegener. 2025 Feb 21;20(1):22. doi: 10.1186/s13024-025-00812-5.

Role of tau versus TDP-43 pathology on medial temporal lobe atrophy in aging and Alzheimer's disease

Wisse LEM, Wuestefeld A, Murray ME, Jagust W, La Joie R.

Alzheimers Dement. 2025 Feb;21(2):e14582. doi: 10.1002/alz.14582.

Disrupted astrocyte-neuron signaling reshapes brain activity in epilepsy and Alzheimer's disease

Wu M, Zhang R, Fu P, Mei Y.

Neuroscience. 2025 Mar 27;570:132-151. doi: 10.1016/j.neuroscience.2025.02.029. Epub 2025 Feb 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias